• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清乙醇测定在肝病患者戒酒控制中的应用

Serum ethanol estimations in the control of alcohol abstinence in patients with liver disease.

作者信息

Staun-Olsen P, Thomsen A C

出版信息

Scand J Gastroenterol. 1979;14(7):785-9. doi: 10.3109/00365527909181405.

DOI:10.3109/00365527909181405
PMID:538408
Abstract

Eighty-eight patients with a non-alcoholic and 105 patients with an alcoholic liver disease were warned against alcohol consumption. On three consecutive ambulatory visits, serum ethanol was measured and compared with patients' admission of alcohol intake. None in the non-alcoholic group had a positive serum ethanol test, whereas 60 samples from 40 patients with alcoholic liver disease were positive. The serum ethanol values were higher in women than in men. Continuation of drinking was unrelated to sex, age, or type of alcoholic liver disease. Twenty-seven of the 40 patients with ethanol in serum denied alcohol consumption. The reliability of the patients was unrelated to sex, age, or type of alcoholic liver disease. Serum ethanol was more valuable than aspartate aminotransferase, alkaline phosphatase, bilirubin, and coagulation factors in pointing out the patients who continued drinking.

摘要

88例非酒精性肝病患者和105例酒精性肝病患者被告诫不要饮酒。在连续三次门诊就诊时,检测血清乙醇水平,并与患者报告的酒精摄入量进行比较。非酒精性肝病组中无人血清乙醇检测呈阳性,而40例酒精性肝病患者的60份样本呈阳性。女性的血清乙醇值高于男性。继续饮酒与性别、年龄或酒精性肝病类型无关。40例血清乙醇检测呈阳性的患者中有27例否认饮酒。患者的可靠性与性别、年龄或酒精性肝病类型无关。在指出继续饮酒的患者方面,血清乙醇比天冬氨酸转氨酶、碱性磷酸酶、胆红素和凝血因子更有价值。

相似文献

1
Serum ethanol estimations in the control of alcohol abstinence in patients with liver disease.血清乙醇测定在肝病患者戒酒控制中的应用
Scand J Gastroenterol. 1979;14(7):785-9. doi: 10.3109/00365527909181405.
2
Gamma-glutamyltranspeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease.γ-谷氨酰转肽酶、天冬氨酸氨基转移酶及红细胞平均体积作为肝病中酒精摄入指标
Scand J Gastroenterol. 1984 Sep;19(6):813-9.
3
Effect of an intravenous infusion of ethanol on serum enzymes and lipids in patients with alcoholic liver disease.静脉输注乙醇对酒精性肝病患者血清酶和血脂的影响。
Gastroenterology. 1980 Apr;78(4):691-5.
4
Casual blood-ethanol estimations in patients with chronic liver disease.慢性肝病患者的随机血液乙醇含量测定
Lancet. 1975 Aug 23;2(7930):345-7. doi: 10.1016/s0140-6736(75)92781-6.
5
Risk factors for alcoholic liver disease in China.中国酒精性肝病的危险因素。
World J Gastroenterol. 2004 Aug 15;10(16):2423-6. doi: 10.3748/wjg.v10.i16.2423.
6
Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.血清硒水平和氧化平衡作为酒精性肝损伤的差异标志物。
Life Sci. 2014 Jan 17;94(2):158-63. doi: 10.1016/j.lfs.2013.10.008. Epub 2013 Oct 21.
7
Clinical significance of serum antibodies against alcohol-altered hepatocyte membrane in alcoholic liver disease.酒精性肝病中抗酒精改变的肝细胞膜血清抗体的临床意义。
Alcohol Clin Exp Res. 1989 Dec;13(6):762-5. doi: 10.1111/j.1530-0277.1989.tb00417.x.
8
[Carbohydrate-deficient transferrin. A new, highly specific marker for chronic alcohol consumption].[缺糖转铁蛋白。一种用于慢性酒精摄入的新型高特异性标志物]
Dtsch Med Wochenschr. 1995 Mar 24;120(12):391-5. doi: 10.1055/s-2008-1055358.
9
Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis.酒精性肝纤维化患者的天冬氨酸氨基转移酶与血小板比值指数
Am J Gastroenterol. 2006 Jul;101(7):1500-8. doi: 10.1111/j.1572-0241.2006.00610.x.
10
Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption.转铁蛋白异常异质性与酒精摄入的临床意义。
Acta Med Scand. 1979;206(4):275-81. doi: 10.1111/j.0954-6820.1979.tb13510.x.